SCHEMBL439462

SCHEMBL439462

CCCC(C)CC=C(C)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.38
CHRM1 P11229 1/20 0.37
AKR1A1 P14550 1/20 0.37
CHRM3 P20309 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
ADRA1A P35348 1/20 0.37
HRH1 P35367 1/20 0.37
DRD3 P35462 1/20 0.37
SLC6A3 Q01959 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ACE2 Q9BYF1 1/20 0.32
CYP3A4 P08684 2/20 0.31
NFKB1 P19838 2/20 0.31
NPSR1 Q6W5P4 2/20 0.31
EP300 Q09472 1/20 0.31
LCK P06239 1/20 0.31
PPARD Q03181 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2785267 1.00 TSHR (0.38) TSHRCHRM1AKR1A1CHRM3HTR2A
SCHEMBL7633511 0.89 ACE2 (0.42) ACE2EP300LCKPPARDZDHHC20
SCHEMBL950317 0.89 ACE2 (0.42) ACE2EP300LCKPPARDZDHHC20
SCHEMBL3289424 0.87 ACE2 (0.49) ACE2EP300LCKPPARDZDHHC20
SCHEMBL14054006 0.85 ACE2 (0.51) ACE2EP300LCKPPARDZDHHC20
SCHEMBL812855 0.85 ACE2 (0.51) ACE2EP300LCKPPARDZDHHC20
SCHEMBL243680 0.85 ACE2 (0.51) ACE2EP300LCKPPARDZDHHC20
SCHEMBL8395628 0.85 ACE2 (0.51) ACE2EP300LCKPPARDZDHHC20
SCHEMBL2695648 0.85 ACE2 (0.51) ACE2EP300LCKPPARDZDHHC20
SCHEMBL8395624 0.85 ACE2 (0.51) ACE2EP300LCKPPARDZDHHC20

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025024325-A2 ALL-ACRYLIC TRIBLOCK AND TETRABLOCK COPOLYMERS HAVING A LACTAM MOIETY AND APPLICATIONS THEREOF ISP INVESTMENTS LLC (US) 2025-01-30 WO claimed
EP-3805313-B1 ACRYLIC ELASTOMER COMPOSITION DENKA COMPANY LTD (JP) 2023-05-03 EP claimed
US-20120094115-A1 COATING COMPOSITION FOR THICK COATING TOAGOSEI CO., LTD. (JP) 2012-04-19 US claimed
WO-2025024325-A2 ALL-ACRYLIC TRIBLOCK AND TETRABLOCK COPOLYMERS HAVING A LACTAM MOIETY AND APPLICATIONS THEREOF ISP INVESTMENTS LLC (US) 2025-01-30 WO disclosed
US-20240408180-A1 IONIC LIQUIDS FOR DRUG DELIVERY PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2024-12-12 US disclosed
EP-4412587-A1 IONIC LIQUIDS FOR DRUG DELIVERY President And Fellows Of Harvard College (US) 2024-08-14 EP disclosed
CN-118382429-A Ionic liquids for drug delivery 哈佛大学校长及研究员协会 2024-07-23 CN disclosed
US-20240217976-A2 COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2024-07-04 US disclosed
US-11999838-B2 Resin additive composition, thermoplastic resin composition, and molded article thereof ADEKA CORPORATION (JP) 2024-06-04 US disclosed
EP-4372042-A2 RESIN ADDITIVE COMPOSITION, THERMOPLASTIC RESIN COMPOSITION, AND MOLDED ARTICLE THEREOF Adeka Corporation (JP) 2024-05-22 EP disclosed
EP-3424993-B1 RESIN ADDITIVE COMPOSITION, THERMOPLASTIC RESIN COMPOSITION, AND MOLDED ARTICLE THEREOF ADEKA CORP (JP) 2024-05-01 EP disclosed
EP-1141053-A1 METHOD FOR PREPARING HALOGENATED COPOLYMERS, RESULTING HALOGENATED POLYMERS AND USE THEREOF SOLVAY (Société Anonyme) (BE) 2001-10-10 EP disclosed
EP-1141052-A1 METHOD FOR PREPARING HALOGENATED COPOLYMERS, RESULTING HALOGENATED COPOLYMERS AND USE THEREOF SOLVAY (Société Anonyme) (BE) 2001-10-10 EP disclosed
WO-2000032659-A1 METHOD FOR PREPARING HALOGENATED COPOLYMERS, RESULTING HALOGENATED COPOLYMERS AND USE THEREOF SOLVAY (SOCIETE ANONYME) (BE) 2000-06-08 WO disclosed
WO-2000032660-A1 METHOD FOR PREPARING HALOGENATED COPOLYMERS, RESULTING HALOGENATED POLYMERS AND USE THEREOF SOLVAY (SOCIETE ANONYME) (BE) 2000-06-08 WO disclosed
EP-0944654-A2 ANIONIC POLYMERISATION OF ACRYLATES AND METHACRYLATES BASF AKTIENGESELLSCHAFT (DE) 1999-09-29 EP disclosed
WO-1998025975-A2 ANIONIC POLYMERISATION OF ACRYLATES AND METHACRYLATES BASF AKTIENGESELLSCHAFT (DE) 1998-06-18 WO disclosed
US-5011560-A Method of adhesion and composition therefor TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1991-04-30 US disclosed
EP-0154819-B1 METHOD OF ADHESION AND COMPOSITION THEREFOR Takeda Chemical Industries, Ltd. (JP) 1988-07-06 EP disclosed
EP-0154819-A1 Method of adhesion and composition therefor Takeda Chemical Industries, Ltd. (JP) 1985-09-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240217976-A2 COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND RAD51, MDM2, UBE2D3 TSHR 3310/4885CHRM1 69/4885AKR1A1 2917/4885
US-20240408180-A1 IONIC LIQUIDS FOR DRUG DELIVERY SLCO4C1, SLC47A1, ABCB11 TSHR 2714/4885CHRM1 4014/4885AKR1A1 4274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.